Cargando…
Diffuse skeletal pain after administration of alendronate
BACKGROUND: Osteoporosis is caused by bone resorption in excess of bone formation, and bisphosphonates, are used to inhibit bone resorption. Alendronate, a biphosphonate, is effective for both the treatment and prevention of osteoporosis in postmenopausal women. Side effects are relatively few and p...
Autores principales: | Ozaras, Nihal, Rezvani, Aylin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941618/ https://www.ncbi.nlm.nih.gov/pubmed/20927253 http://dx.doi.org/10.4103/0253-7613.68435 |
Ejemplares similares
-
Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008) -
Differential diagnosis of multiple vertebral compression: butterfly
vertebrae
por: Ozaras, Nihal, et al.
Publicado: (2015) -
Functional limitations due to foot involvement in
spondyloarthritis
por: Ozaras, Nihal, et al.
Publicado: (2016) -
Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy
por: Lin, Tsung-Li, et al.
Publicado: (2013) -
Long-Term Alendronate Use Not without Consequences?
por: Somford, M. P., et al.
Publicado: (2009)